Health / Medical Topics

    Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells

    A cell based cancer vaccine composed of mature polarized dendritic cells (DCs) and pulsed with apoptotic autologous tumor cells that has potential immunostimulating and antineoplatic activities. Dendritic cells (DCs) were treated with interleukin-1beta, tumor necrosis factor alpha, interferon-alpha (IFN-a), IFN-gamma and polyinosinic:polycytidylic acid (p-I:C) to produce mature alpha type-1 polarized DCs (alphaDC1) that are capable of producing high levels of interleukin-12p70 (IL-12p70). The alphaDC1 are subsequently pulsed with apoptotic autologous tumor cells. Upon administration, these DCs are able to induce a potent cytotoxic T lymphocyte (CTL) response against tumor associated antigens (TAAs), resulting in tumor cell lysis and inhibition of tumor cell growth. Apoptotic tumor cells contain an array of TAAs. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Pertaining to apoptosis.
    Found only in the cytosol, TP53BP2 impedes cell cycle progression beyond G2/M. It enhances p53 trans-activation function and induces p21 (CDKN1A)…
    Apoptosis-stimulating of p53 protein 1 (1090 aa, ~120 kDa) is encoded by the human PPP1R13B gene. This protein plays a role in…
    Apoptosis-associated speck-like protein containing a CARD (195 aa, ~22 kDa) is encoded by the human PYCARD gene. This protein plays a role…
    Apoptosis regulator Bcl-2 (239 aa, ~26 kDa) is encoded by the human BCL2 gene. This protein plays a role in cellular…
    Apoptosis regulator BAX (192 aa, ~21 kDa) is encoded by the human BAX gene. This protein plays a role in both apoptosis…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact